12Nov/13

Leica Biosystems Launches Independently Qualified Menu of IHC Antibodies for … – SelectScience.net (press release)

Leica Biosystems Launches Independently Qualified Menu of IHC Antibodies for …
SelectScience.net (press release)
Leica Biosystems Launches Independently Qualified Menu of IHC Antibodies for Hematopathology. 12 Nov 2013. Leica Biosystems announces the launch of the fourth Novocastra™ HD menu, focused on hematopathology. Previously launched were the …

12Nov/13

Leica Biosystems Launches Independently* Qualified Menu of IHC Antibodies … – PR Newswire (press release)

Leica Biosystems Launches Independently* Qualified Menu of IHC Antibodies …
PR Newswire (press release)
Leica Biosystems announces the launch of the fourth Novocastra™ HD menu, focused on hematopathology. Previously launched were the Novocastra HD menus for breast, head & neck and dermatopathology. The new Novocastra HD menu for …

and more »

08Nov/13

Peregrine's Bavituximab in Combination With Anti-CTLA-4 Antibodies Yields … – Benzinga

Peregrine’s Bavituximab in Combination With Anti-CTLA-4 Antibodies Yields …
Benzinga
Peregrine Pharmaceuticals (NASDAQ: PPHM) today announced the presentation of data at the Society for Immunotherapy of Cancer (SITC) Annual Meeting in National Harbor, Maryland being held November 7-10. The data showed that phosphatidylserine …
Data Presentation at Society for Immunotherapy of Cancer Annual Meeting …MENAFN.COM

all 2 news articles »

07Nov/13

Monoclonal Antibodies Market in Breast Cancer with 2019 Forecasts in New … – PR Web (press release)

Monoclonal Antibodies Market in Breast Cancer with 2019 Forecasts in New …
PR Web (press release)
RnRMarketResearch.com adds Latest Report on “Monoclonal Antibodies Market in Breast Cancer to 2019 – Strong Uptake of Novel HER-2 Targeted Therapies to Drive Robust Growth” to its store. Share on Twitter Share on Facebook Share on Google+ …
Breast Cancer mAbs Market Worth 10.6B by 2019 in 8 CountriesMENAFN.COM

all 2 news articles »